Drugs Prescribed for Type 2 Diabetes Could Protect Against Parkinson’s

Drugs Prescribed for Type 2 Diabetes Could Protect Against Parkinson’s

Diabetes October 17, 2017 at 10:16 AM 0 comments

GLITAZONES (GTZ), a type of drug prescribed to Type 2 diabetes patients to improve insulin sensitivity, may convey protective qualities against Parkinson’s disease, suggests a study performed at the University of Bergen, Bergen, Norway. There have been numerous studies linking Type 2 diabetes millitus to the onset of Parkinson’s disease;Read More

Type 1 Diabetics One Step Closer to Single Insulin Injection Per Day

Type 1 Diabetics One Step Closer to Single Insulin Injection Per Day

Diabetes October 17, 2017 at 10:14 AM 0 comments

GLUCOSE-RESPONSIVE insulin (GRI) has the potential to change the lives of many Type 1 diabetes mellitus patients by reducing the number of insulin injections they require to just one per day; however, its effects are currently hard to predict. Now, a computer model created by researchers at the Massachusetts InstituteRead More

Researchers who Discovered the Mechanisms of the Circadian Rhythm Awarded the 2017 Nobel Prize in Physiology or Medicine

Uncategorized October 16, 2017 at 3:20 PM 0 comments

“Ever since the emergence of life on Earth, about 4 billion years ago, evolving lifeforms had to adapt to the rotation of our planet. The ability to prepare for the regular daily fluctuations is crucial for all lifeforms. But how is this possible? This year’s Nobel laureates have been studyingRead More

Fire Ant Venom: A New Compound Discovered for Psoriasis Treatment

Fire Ant Venom: A New Compound Discovered for Psoriasis Treatment

Dermatology October 9, 2017 at 9:33 AM 0 comments

INTRIGUING new research has found that specific compounds present in fire ant venom have the potential to form a new, topical treatment for psoriasis. The results of a collaboration study between Emory University, Atlanta, Georgia and Case Western University, Cleveland, Ohio, USA, found that a compound derived from fire antRead More

Advanced Stage III Melanoma: Brand New Adjuvant Therapy Discovered

Advanced Stage III Melanoma: Brand New Adjuvant Therapy Discovered

Dermatology October 9, 2017 at 9:32 AM 0 comments

A NOVEL combination of dabrafenib and trametinib has proven a successful adjuvant therapy for Stage III BRAF-mutant melanoma patients, doubling relapse-free survival time. The COMBI-AD trial, described at the ESMO 2017 Congress in Madrid, Spain, was the first of its kind for adjuvant treatment for Stage III melanoma, as reportedRead More

Studying Protein Networks in Bowel Cancer

Studying Protein Networks in Bowel Cancer

Gastroenterology October 3, 2017 at 9:07 AM 0 comments

PROTEOMIC study of bowel cancer cells identifies common protein mutations and allows the prediction of treatment response. For the first time, scientists have studied the role of proteins in bowel cancer pathogenesis with the hope of increasing our understanding of the underlying pathway of this common cancer and moving towardsRead More

Role of Gut Bacteria as a Parkinson’s Disease Biomarker

Role of Gut Bacteria as a Parkinson’s Disease Biomarker

Gastroenterology October 3, 2017 at 9:06 AM 0 comments

BACTERIAL communities in the gut of Parkinson’s patients differ to those of healthy people, potentially providing an early indicator of the neurodegenerative disease from a source outside of the brain. Experts have long postulated that Parkinson’s disease originates in a different location to where it manifests; however, until recently itRead More

Liver Disease: A Potential Protective Treatment Opportunity

Liver Disease: A Potential Protective Treatment Opportunity

Hepatology September 22, 2017 at 1:45 PM 0 comments

PROTECTION against alcoholic liver disease may become possible thanks to new research surrounding the protein fibroblast growth factor 21 (FGF21). A recent study, conducted by a team of researchers at the Beth Israel Deaconess Medical Center (BIDMC), Boston, Massachusetts, USA and colleagues from the University of Pennsylvania, Philadelphia, Pennsylvania, USA,Read More

New Therapeutic Target for Liver Cancer Revealed

New Therapeutic Target for Liver Cancer Revealed

Hepatology September 22, 2017 at 1:41 PM 0 comments

PIONEERING research from the University of Maryland, Baltimore, Maryland, USA, has found a potential link between a relatively under-studied gene and liver cancer. The gene, named SLC13A5, is responsible for the production of a protein that transports citrate into various cells and is mainly expressed in the liver. Dr HongbingRead More

Urinary Tract Infection Resistant Mutation Identified

Urinary Tract Infection Resistant Mutation Identified

Urology September 22, 2017 at 1:39 PM 0 comments

A MUTATION altering the effect that levofloxacin, a quinolone antibiotic, has on pathogens causing urinary tract infections (UTI) has been identified by a study conducted by the College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA. The research was part of a larger study to determine risk factors forRead More